Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
16.09 BRL | -3.24% | -1.77% | -7.85% |
May. 08 | Transcript : Wilson Sons S.A., Q1 2024 Earnings Call, May 08, 2024 | |
May. 08 | EARNINGS: International Biotechnology bullish; Andrews Sykes profit up | AN |
Sales 2024 * | 469M 2.39B | Sales 2025 * | 544M 2.78B | Capitalization | 1.38B 7.07B |
---|---|---|---|---|---|
Net income 2024 * | 69M 352M | Net income 2025 * | 77M 393M | EV / Sales 2024 * | 3.99 x |
Net Debt 2024 * | 484M 2.47B | Net Debt 2025 * | 464M 2.37B | EV / Sales 2025 * | 3.39 x |
P/E ratio 2024 * |
20
x | P/E ratio 2025 * |
17.8
x | Employees | 3,800 |
Yield 2024 * |
2.51% | Yield 2025 * |
2.83% | Free-Float | 43.48% |
Latest transcript on Wilson Sons S.A.
1 day | -3.24% | ||
1 week | -1.77% | ||
Current month | -4.23% | ||
1 month | -4.23% | ||
3 months | -4.45% | ||
6 months | +5.58% | ||
Current year | -7.85% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 54 | 15-12-31 | |
Chairman | 64 | 93-12-31 | |
Chief Operating Officer | 67 | 79-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
William Salomon
BRD | Director/Board Member | 66 | - |
Chairman | 64 | 93-12-31 | |
Director/Board Member | 74 | 90-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 34 M€ | +3.87% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 16.09 | -1.29% | 577,200 |
24-05-16 | 16.3 | -0.31% | 635,600 |
24-05-15 | 16.35 | 0.00% | 297,700 |
24-05-14 | 16.35 | -0.18% | 549,500 |
24-05-13 | 16.38 | 0.00% | 399,100 |
Delayed Quote Sao Paulo, May 17, 2024 at 04:07 pm EDT
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-7.85% | 1.38B | |
+35.33% | 11.78B | |
+20.55% | 6.39B | |
+7.59% | 2.52B | |
-13.75% | 2.02B | |
+11.44% | 1.84B | |
+37.54% | 1.22B | |
+20.28% | 1.03B | |
-.--% | 989M | |
+8.62% | 685M |
- Stock Market
- Equities
- PORT3 Stock